Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...

Jan. 27—Dr. Altagrace Hanley, medical director at La Boussole Medical Spa & Wellness Center, has achieved board certification in obesity medicine. La Boussole's program includes advanced options ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Obesity is currently defined ... Dr. Jennifer Miao is a board-certified cardiologist and critical care fellow at Yale School of Medicine/YNHH. She is a fellow in the ABC medical news unit.

Using obesity ... a board and then giving one person a hammer and another person, you know, like a chopstick,” Varney said, adding, "we’re leveling the playing field with these medications.” ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive Versant's backing in ...

using the medications ... who treats patients with obesity at UVA Health in Charlottesville, Virginia. “It’s like telling somebody to nail a nail into a board and then giving one person ...

This shows the need for a better way to diagnose obesity. While BMI can be helpful as a first step, the experts suggest it’s not enough on its own. Mir Ali, MD, board certified general surgeon ...